Endogenous Endophthalmitis and Other Ocular Manifestations of Injection Drug Use

Preston M. Luong; Edmund Tsui; Nikhil N. Batra; Michael E. Zegans


Curr Opin Ophthalmol. 2019;30(6):506-512. 

In This Article


During the current opioid epidemic, injection drug use-related harms continue to be a prevalent healthcare concern. Endogenous endophthalmitis, HIV-associated ocular pathology, and embolic ocular phenomena represent serious threats to vision in IDUs. In particular, the incidence of endogenous endophthalmitis may have increased as injection drug use continues to rise. As IDUs represent a distinct population that is generally younger and delay seeking care, it is important for ophthalmologists, primary care providers, and internists to inquire about ocular symptoms in patients with a positive history of injection drug use for prompt recognition and initiation of potential vision-saving treatment.